IRMDIRADIMED CORP
Surgical & Medical Instruments & Apparatus
- Revenue
- $84M
- 14% YoY
- Operating margin
- 31.2%
- 4.0% YoY
- EBITDA
- $27M
- 20% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear111% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear68% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $42M | $53M | $66M | $73M | $84M | 14% |
| Operating income | $10M | $16M | $20M | $22M | $26M | 19% |
| Net income | $9M | $13M | $17M | $19M | $22M | 17% |
| Operating cash flow | $11M | $10M | $13M | $26M | $25M | 2.6% |
| Capex | $482K | $823K | $7M | $8M | $8M | 3.0% |
| Stock-based comp | $1M | $1M | $2M | $3M | $3M | 16% |
| Dividends | — | $13M | $13M | $14M | $15M | 10.0% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $1M · 3
- Net
- −$1M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $781K | $781K | 368 | — |
| FY2024 | $690K | $690K | 205 | — |
| FY2023 | $643K | $643K | 175 | — |